BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22899340)

  • 41. Analysis of the human CD21 transcription unit reveals differential splicing of exon 11 in mature transcripts and excludes alternative splicing as the mechanism causing solubilization of CD21.
    Illges H; Braun M; Peter HH; Melchers I
    Mol Immunol; 1997 Jul; 34(10):683-93. PubMed ID: 9430196
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiphospholipid syndrome patients display reduced titers of soluble CD21 in their sera irrespective of circulating anti-beta2-glycoprotein-I autoantibodies.
    Singh A; Blank M; Shoenfeld Y; Illges H
    Rheumatol Int; 2008 May; 28(7):661-5. PubMed ID: 18172655
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and phenotypic features of CD5-negative B cell chronic lymphoproliferative disease resembling chronic lymphocytic leukemia.
    Romano C; Sellitto A; Chiurazzi F; Simeone L; De Fanis U; Raia M; Del Vecchio L; Lucivero G
    Int J Hematol; 2015 Jan; 101(1):67-74. PubMed ID: 25432435
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of Smooth Muscle Myosin Heavy Chain as an Effective Marker of Follicular Dendritic Cells.
    Ioannidis I; Laurini JA
    Appl Immunohistochem Mol Morphol; 2019 Jan; 27(1):48-53. PubMed ID: 28549038
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lymph node biopsy in chronic lymphocytic leukemia: prognostic significance of histopathological, morphometry and immunohistological findings.
    Raphael M; Debré P; Guigui B; Binet JL
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):379-83. PubMed ID: 3265507
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
    Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
    Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinicopathological and immunophenotypic studies on 12 cases with B cell chronic lymphocytic leukemia.
    Nakamura N; Suzuki S; Segami H; Nozawa Y; Tominaga K; Wachi E; Hojo H; Abe M; Sakuma H; Wakasa H
    Pathol Int; 1994; 44(10-11):779-84. PubMed ID: 7834079
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of the Epstein-Barr virus receptor CD21 in multiple sclerosis.
    Toepfner N; Cepok S; Grummel V; Hemmer B
    J Neuroimmunol; 2012 Jan; 242(1-2):47-51. PubMed ID: 22137275
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Apoptotic and proliferative characteristics of proliferation centers in lymph node sections of patients with chronic lymphocytic leukemia.
    Sachanas S; Levidou G; Angelopoulou MK; Moschogiannis M; Yiakoumis X; Kalpadakis C; Vassilakopoulos TP; Kontopidou F; Tsirkinidis P; Dimitrakopoulou A; Kokoris S; Dimitriadou E; Kyrtsonis MC; Panayiotidis P; Papadaki H; Patsouris E; Korkolopoulou P; Pangalis GA
    Leuk Lymphoma; 2014 Mar; 55(3):571-82. PubMed ID: 23697878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells.
    Romano C; De Fanis U; Sellitto A; Dalla Mora L; Chiurazzi F; Giunta R; Rotoli B; Lucivero G
    Leuk Lymphoma; 2003 Nov; 44(11):1963-71. PubMed ID: 14738151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD21/CD35 in B cell activation.
    Carroll MC
    Semin Immunol; 1998 Aug; 10(4):279-86. PubMed ID: 9695184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Silencing of CD21 expression in synovial lymphocytes is independent of methylation of the CD21 promoter CpG island.
    Schwab J; Illges H
    Rheumatol Int; 2001 May; 20(4):133-7. PubMed ID: 11411956
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Soluble forms of CD21 and CD23 antigens in the serum in B cell chronic lymphocytic leukaemia.
    Lowe J; Brown B; Hardie D; Richardson P; Ling N
    Immunol Lett; 1989 Jan; 20(2):103-9. PubMed ID: 2523865
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The levels of soluble forms of CD21 and CD83 in multiple sclerosis.
    Karampoor S; Zahednasab H; Etemadifar M; Keyvani H
    J Neuroimmunol; 2018 Jul; 320():11-14. PubMed ID: 29759135
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Decreased levels of sCD21 and sCD23 in blood of patients with systemic-juvenile arthritis, polyarticular-juvenile arthritis, and pauciarticular-juvenile arthritis.
    Singh A; Vastert SJ; Prakken BJ; Illges H
    Rheumatol Int; 2012 Jun; 32(6):1581-7. PubMed ID: 21328056
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of functional sphingosine-1 phosphate receptor-1 is reduced by B cell receptor signaling and increased by inhibition of PI3 kinase δ but not SYK or BTK in chronic lymphocytic leukemia cells.
    Till KJ; Pettitt AR; Slupsky JR
    J Immunol; 2015 Mar; 194(5):2439-46. PubMed ID: 25632006
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.
    Herishanu Y; Pérez-Galán P; Liu D; Biancotto A; Pittaluga S; Vire B; Gibellini F; Njuguna N; Lee E; Stennett L; Raghavachari N; Liu P; McCoy JP; Raffeld M; Stetler-Stevenson M; Yuan C; Sherry R; Arthur DC; Maric I; White T; Marti GE; Munson P; Wilson WH; Wiestner A
    Blood; 2011 Jan; 117(2):563-74. PubMed ID: 20940416
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals.
    Moir S; Malaspina A; Ogwaro KM; Donoghue ET; Hallahan CW; Ehler LA; Liu S; Adelsberger J; Lapointe R; Hwu P; Baseler M; Orenstein JM; Chun TW; Mican JA; Fauci AS
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10362-7. PubMed ID: 11504927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of new phosphorylation sites of CD23 in B-cells of patients with chronic lymphocytic leukemia.
    Maďarová M; Mucha R; Hresko S; Makarová Z; Gdovinová Z; Szilasiová J; Vitková M; Guman T; Štecová N; Dobransky T
    Leuk Res; 2018 Jul; 70():25-33. PubMed ID: 29763855
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deep Phenotyping of CD11c
    Rincon-Arevalo H; Wiedemann A; Stefanski AL; Lettau M; Szelinski F; Fuchs S; Frei AP; Steinberg M; Kam-Thong T; Hatje K; Keller B; Warnatz K; Radbruch A; Lino AC; Schrezenmeier E; Dörner T
    Front Immunol; 2021; 12():635615. PubMed ID: 33777025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.